News and Comments

AGEN: IRRATIONAL REACTION AGAINST EXPECTED NEWS

  Thursday, March 20, 2014
 More...

PROSENSA: BACK INTO THE LIMELIGHT

  Tuesday, March 18, 2014

Prosensa Holding N.V. (RNA) might have good news that was made possible through insightful observation following past results that almost condemned the Dutch biopharmaceutical company’s compound drisapersen for the treatment of Duchenne Muscular Dystrophy (DMD).  More...

JAKAFI DEVELOPED BY INCYTE MET THE PRIMARY ENDPOINTS FOR POLYCYTHEMIA VERA

  Friday, March 07, 2014

Incyte (INCY) announced results from pivotal Phase 3 trial of Jakafi (ruxolitinib) in polycythemia vera patients who are resistant to or intolerant of hydroxyurea. The results met the primary endpoints; achieving phlebotomy independence and reducing spleen size by 35 percent or more compared to best available therapy.  More...


Recent Postings


Archive


Tags

Prolor Biotech (PBTH) Elan (ELN) JOUNCE THERAPEUTICS (JNCE) Revlimid (lenolidamide) Anadys (ANDS) CompuGen (CGEN) Roche (ROCHE) NANTKWEST (NK) TOKAI (TKAOI) ImmunoGen (IMGN) Biocryst (BCRX) Prosensa (RNA) HALOZYME (HALO) Herceptin Galena (GALE) Human Genome Sciences (HGSI) PTC Therapeutics (PTCT) GlycoMimetics (GLYN) AstraZeneca (AZN) Illumina (ILMN) Mirati Therapeutics (MRTX) Alder Biopharmaceuticals (ALDR) Sanofi (SNY) CRISPR Therapeutics (CRSP) Rapamune Human Longevity (HLI) LEXICON (LXRX) Trastuzumab-DM1 Pluristem (PSTI) Adaptimmune (ADAP) Genentech Ionis (IONS) Dendreon (DNDN) IDERA (IDRA) JUNO (JUNO) Agenus (AGEN Benlysta (belimumab) Vertex (VRTX) Ariad (ARIA) MODERNA Idenix (IDIX) Regeneron (REGN) Spike Therapeutics (ONCE) SYNTA (SNTA) Zerenex Aimmune Therapeutics (AIMT) OncoCyte (OCX) Valeant Pharmaceuticals International (VRX) Sequenom (SQNM) AGOS (ARGS) Exelixis (EXEL) Auspex (ASPX) KITE (KITE) Intercept (ICPT) Ocular Therapeutix (OCUL) Alnylam (ALNY) Epizyme (EPZM) Roche (RHHBY) Micromet (MITI) ARCA (ABIO) Intermune (ITMN) Ridaforolimus NOVOCURE (NVCR) OSI (OSIP) Sanofi (SNA) Jazz Pharmaceuticals (JAZZ) Theravance (THRX) Tysabri Gilead (GILD) Endometrial Cancer ARGOS (ARGS) Seattle Genetics (SGEN) RenenxBio (RGNX) Bristol-Myers Squibb (BMY) Incyte (INCY) Anacor (ANAC) GUARDIAN HEALTH ZALTRAP™ Vitae Pharmaceuticals (VTAE) REGULUS (RGLS) Onyx (ONXX) BIOMARIN (BMRN) Sarepta (SRPT) Theravance Bio Pharma (TBPH) KERYX (KERX) ACADIA (ACAD) Bellicum (BLCM) ADVENTRIX (ANX) SUNESIS PHARMACEUTICALS (SNSS) Abbott Laboratories (ABT) PORTOLA (PTLA) Velcade (bortezomib) Editas (EDIT) INNOVIVA (INVA) Sangamo (SGMO) C4 Therapeutics Intrexon (XON) Advaxis (ADXS) Akebia Therapeutics (AKAB) Ziofpharm (ZIOP) Xoma (XOMA) VANDA (VNDA) Multiple Myeloma Biogen Idec (BIIB) Array Pharmaceuticals (ARRY) Inovio (INO) ISIS (ISIS) CEMPRA (CEMP) Dynavax (DVAX) AERIE PHARMACEUTICALS ABBVIE (ABBV) NEKTAR (NKTR)) NEUROCRINE (NBIX) galapagos (GLPG) Amgen (AMGN) Merck (MRK) GlaxoSmithKline (GSK) Cytokinetics (CYTK) Sanofi-Aventis (SAN) Telaprevir Global Cell Therapeutics (GBT) SERES THERAPEUTICS (MCRB) Agenus (AGEN)